Results 121 to 130 of about 28,600 (213)

Olanzapine effectiveness on weight gain in anorexia nervosa patients: systematic review and meta-analysis. [PDF]

BMC Psychiatry
Alqurashi BF, Alserihi AR, Albariqi A, Alenazi AA, Alhindi Y, Alghamdi RL, Alotaibi BA, Abanmi SN, Alhejaili FA, Nahhas FH.   +9 more
europepmc   +1 more source

A Cross‐Sectional Study of Prescribed Sleep Medication Use and Its Clinical and Demographic Factors Among Young People Receiving Mental Health Crisis Interventions in Sydney, Australia

Journal of Child and Adolescent Psychiatric Nursing, Volume 39, Issue 3, August 2026.
ABSTRACT Background Clinical and demographic factors influencing prescribed sleep medication use in children and young people (CYP) have been studied inadequately. We aimed to examine the prevalence of prescribed sleep medication use among CYP experiencing mental health crises and its associations with clinical and demographic factors.
Md Nazmul Huda, Hasan Jamali, Mobarrat Monir, Avick Rahman, Anne‐Marie Schlesinger, Ingrid Bartrop, Giles Barton, Alvira Hurst, Craig Andrews, Valsamma Eapen, Rajeev Jairam   +10 more
wiley   +1 more source

Anticholinergic Medication Use in Veterans Affairs Long‐Term Care Residents: Clinical Patterns and Opportunities for Deprescribing

Journal of the American Geriatrics Society, Volume 74, Issue 8, Page 2285-2296, August 2026.
ABSTRACT Background Anticholinergic exposure is common in nursing homes; however, the true burden may be underestimated, particularly due to over‐the‐counter agents such as first‐generation antihistamines that are not consistently captured in prior claims‐based studies.
Cellas A. Hayes, Yongmei Li, Bocheng Jing, Laura A. Graham, Chintan Dave, Michelle C. Odden   +5 more
wiley   +1 more source

Olanzapine for Extended-Release Injectable Suspension for Subcutaneous Use (TV-44749) Designed to Avoid the Risk of PDSS: In Vitro Release Studies in Human Plasma and In Vivo Impact of Extrinsic Factors on Pharmacokinetics. [PDF]

Pharmaceutics
Bibi D, Steiner L, Krtalic I, Juretic M, Cetina-Cizmek B, Komlosi A, Loupe P, Ferderber K, Hallak H.   +8 more
europepmc   +1 more source

Triggers, Responses, and Outcomes for Patient Related Violence and/or Aggression Events During Acute Hospitalisation: A Documentary Analysis

Journal of Clinical Nursing, Volume 35, Issue 8, Page 3418-3430, August 2026.
ABSTRACT Aim To examine triggers, responses, and outcomes for patient‐related violence and/or aggression events during acute hospitalisation. Design This was a descriptive observational study undertaken at two healthcare organisations. Methods Pre‐existing data were extracted from organisational incident reports and individual medical records during a ...
Debra Kerr, Alison M. Hutchinson, Elisa Ilarda, Louise Alexander, Susan Perlen, Nicole Davies, Trish Mant, Angela Skazlic, Joanna Petrunic, Rachel Mrhar, Adam Searby   +10 more
wiley   +1 more source

Olanzapine-Associated Hepatotoxicity in Bipolar Disorder: A Multicenter Real-World Study of Prevalence, Risk Factors, and Outcomes. [PDF]

Drug Des Devel Ther
Wang F, Lai X, Zhou S, Lin J, Xin H, Tao Z, Wang X, Zhang S, Liu Z, Tan H, Xiong Y.   +10 more
europepmc   +1 more source

Potential of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Mitigating Metabolic Side Effects Associated With Clozapine or Olanzapine Therapy: A Literature Review. [PDF]

Cureus
Meftah A, Yoade B, Cowart C, Choi A, Popoola O, Afe O, Efremoff S, Ezema C, Johnson B, Lawrence J, Olupona T.   +10 more
europepmc   +1 more source

Correction: Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes. [PDF]

CNS Drugs
Wang E, Liu Y, Wang Y, Han X, Zhou Y, Zhang L, Tang Y.   +6 more
europepmc   +1 more source

Successful Treatment of Rapid Cycling Bipolar Disorder With Lurasidone, Clozapine, and Valproate: A Case Report

Bipolar Disorders, Volume 28, Issue 5, August 2026.
Petr Potměšil, Miloslav Kopeček, Veronika Andrashko   +2 more
wiley   +1 more source

Advancing Cancer Cachexia Drug Development: Leveraging Biomarkers and Functional Endpoints to Optimize Trial Design. [PDF]

Cancer Rep (Hoboken)
Othman NO, Habib H, Almeldin DM, Shohdy KS.   +3 more
europepmc   +1 more source